Clinical Trials Directory

Trials / Completed

CompletedNCT00390481

Study of Carotid Occlusion and Neurocognition

Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
294 (estimated)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To determine the relationship between cognitive functioning and blood flow in the brain among patients randomized to either extracranial-intracranial (EC-IC) bypass or medical therapy alone in the Carotid Occlusion Surgery Study (COSS).

Detailed description

The Carotid Occlusion Surgery Study (COSS) evaluates whether a surgical operation, EC-IC bypass surgery, can reduce the chance of a stroke in someone who has complete blockage in one main artery in the neck that supplies blood to the brain (the carotid artery). The operation bypasses the blockage so more blood can flow to the brain. Only people with decreased blood flow to the brain, as demonstrated on a PET (positron emission tomographic) scan, are randomized into the COSS study. Among patients randomized into the COSS study, RECON will evaluate whether restoring the blood flow to the brain (with EC-IC bypass surgery) will also improve mental functioning. Participants in both the surgical and medical groups of the COSS study will participate in the RECON study. By comparing the mental functioning of the participants in both treatment groups over the course of 2 years, the investigators hope to determine whether the EC-IC bypass operation also helps improve or maintain mental functioning.

Conditions

Interventions

TypeNameDescription
PROCEDUREEC-IC Bypass in the COSS studyEC-IC Bypass surgery involves taking an artery from the scalp outside the skull, making a small hole in the skull, and then connecting the scalp artery to a brain artery inside the skull. In this way, the blockage of the carotid artery in the neck is bypassed and more blood can flow to the brain.

Timeline

Start date
2004-11-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2006-10-19
Last updated
2013-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00390481. Inclusion in this directory is not an endorsement.